Adverse Events

Bone Pain Reduced With Pegfilgrastim Administration 72 Hours After Chemo

Bone Pain Reduced With Pegfilgrastim Administration 72 Hours After Chemo

2 hours ago

2 min read

Injectable, Extended-Release Buprenorphine Feasible for Opioid Use Disorder During Pregnancy

Injectable, Extended-Release Buprenorphine Feasible for Opioid Use Disorder During Pregnancy

Mar 20, 2026

1 min read

Prenatal Valproate Exposure Tied to Offspring Neurodevelopmental Risks

Prenatal Valproate Exposure Tied to Offspring Neurodevelopmental Risks

Mar 19, 2026

1 min read

Improved Survival But More Adverse Events Seen for Women With Cancer

Improved Survival But More Adverse Events Seen for Women With Cancer

Mar 18, 2026

1 min read

Anticholinergic Drug Burden Linked to Increased Risk for Cardiovascular Events

Anticholinergic Drug Burden Linked to Increased Risk for Cardiovascular Events

Mar 12, 2026

2 min read

Apixaban Safer Than Rivaroxaban for Treatment of Acute Venous Thromboembolism

Blood Disorders

Apixaban Safer Than Rivaroxaban for Treatment of Acute Venous Thromboembolism

Mar 12, 2026

1 min read

Genetic Testing Plays Role in Identifying Malignant Hyperthermia Risk

Genetic Testing Plays Role in Identifying Malignant Hyperthermia Risk

Mar 11, 2026

1 min read

Obinutuzumab Superior to Placebo for Adults With Active Systemic Lupus Erythematosus

Obinutuzumab Superior to Placebo for Adults With Active Systemic Lupus Erythematosus

Mar 10, 2026

2 min read

AAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for Osteoporosis

AAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for Osteoporosis

Mar 06, 2026

1 min read

Read More

www.healthday.com